Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STRIVE: Immune Modulation Strategy Trial for COVID-19
NCT05822583Phase 4Completed
- Sponsor
- University of Minnesota
- Start
- Jul 2023
- Primary completion
- Jun 2025
- Modality
- Fc-Fusion Proteins
- Countries
- 19
01
Overview
A Phase 4 trial of abatacept in coronavirus disease 2019 (COVID-19), sponsored by University of Minnesota. Started Jul 2023; status: completed.
02
Drugs
abatacept
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05822583.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05822583.